Filaments loaded with griseofulvin (GF), a model poorly water-soluble drug, were prepared and used for 3D printing via fused deposition modeling (FDM). GF was selected due to its high melting temperature, enabling lower temperature hot-melt extrusion (HME) keeping GF largely crystalline in the filaments, which could help mitigate the disadvantages of high HME processing temperatures such as filament quality, important for printability and the adverse effects of GF recrystallization on tablet properties. Novel aspects include single-step fusion-assisted ASDs generation during FDM 3D printing and examining the impact of tablet surface areas (SA) through printing multi-mini and square-pattern perforated tablets to further enhance drug supersaturation during dissolution. Kollicoat protect and hydroxypropyl cellulose were selected due to their low miscibility with GF, necessary to produce crystalline filaments. The drug solid-state was assessed via XRPD, DSC and FT-IR. At 165 °C HME processing temperature, the filaments containing ~80% crystalline GF were printable. Fusion-assisted 3D printing led to GF supersaturation of ~153% for cylindrical tablets and ~293% with the square-pattern perforated tablets, indicating strong monotonous impact of tablet SA. Dissolution kinetics of drug release profiles indicated Fickian transport for tablets with higher SA, demonstrating greater SA-induced drug supersaturation for well-designed 3D printed tablets.
The robustness of 3D-printed mini-tablets as a platform to administer milligram dosages, intended for age-specific therapy, without the need of tablet splitting while maintaining similar release profiles, was investigated. Griseofulvin, as a model poorly water-soluble drug, and hydroxypropyl cellulose along with Kollicoat Protect as polymers were used to prepare filaments at 1–20% drug concentrations via hot-melt extrusion (HME). Higher drug concentrations served for testing the feasibility of a reduced number of mini-tablets to be administered. A reliable dose titration in the range 0.19–3.91 mg at a high accuracy (R2 of 0.999) was achieved through composite unit (multi-unit) mini-tablets. All mini-tablets produced had excellent content uniformity and their label claim values were within the acceptable range, proving that HME processing followed by 3D printing promotes content uniformity even for mini-tablets containing low drug doses (0.19 mg). Remarkably, the proposed approach allowed achieving similar drug release profiles via composite unit mini-tablets as well as single mini-tablets at high drug concentrations. In contrast, split tablets demonstrated different release behaviors, attributed to their size and shape differences. Overall, the distinct advantages of mini-tablets to provide dose flexibility while maintaining similar release profiles was demonstrated.
15 October 2024 in International Journal of Pharmaceutics
As predicted by the multi-asperity particle contact model, powder cohesion can be significantly reduced through dry coating of silica using a high-intensity vibratory mixer (HIVM). To promote industry adoption of dry coating, industry-relevant devices, a low-intensity V-blender and a medium-intensity comil, were evaluated against HIVM as a benchmarking control. Since low/medium intensity devices could lead to less effective silica dispersion, the contact model was extended to account for silica agglomeration. Three model APIs, belonging to very cohesive and cohesive flow category, were coated with two silica types (A200 and R972P) for enhancing flow (flow function coefficient - FFC) and conditioned bulk density (CBD). The V-blender exhibited least improvements in FFC and CBD. Corresponding SEM images revealed poor silica dispersion and presence of large porous agglomerates on coated API surfaces. Comil, at one and five passes with different-sized screens, performed better than V-blender. While FFC and CBD improved, some silica agglomeration on API surfaces was evident. HIVM, due to well-dispersed silica coating, achieved the most significant, 2-3 category enhancements in FFC and CBD at higher intensities. These results, in line with the extended model predictions, indicated that whereas V-blender would be unsuitable for dry coating due to excessive silica agglomeration, comil with finer screens would be a promising continuous manufacturing option for enhancing fine powder flowability. Device equivalence analysis identified lower intensity HIVM operating conditions that could achieve performance comparable to best outcomes from V-blender or comil; potentially enabling HIVM as a surrogate material sparing screening device.